Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
Rhea-AI Summary
Rigel Pharmaceuticals (Nasdaq: RIGL), a biotechnology company focused on hematologic disorders and cancer therapies, will report its second quarter 2025 financial results after market close on Tuesday, August 5, 2025.
The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss financial results and provide a business update. Investors can join via phone or access the webcast through Rigel's investor relations website, where it will remain available for replay for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction 9 Alerts
On the day this news was published, RIGL declined 0.45%, reflecting a mild negative market reaction. Argus tracked a peak move of +2.5% during that session. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $382M at that time.
Data tracked by StockTitan Argus on the day of publication.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email: david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2025-financial-results-and-business-update-302515528.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When will Rigel Pharmaceuticals (RIGL) report Q2 2025 earnings?
How can investors access Rigel's Q2 2025 earnings call?
What time is Rigel's Q2 2025 earnings call?
How long will Rigel's Q2 2025 earnings webcast be available for replay?
What is Rigel Pharmaceuticals' main business focus?
